UCB Selects Rowen for $2B Biopharmaceutical Manufacturing Campus

Go back to UCB Selects Rowen for $2B Biopharmaceutical Manufacturing Campus
(NYSE: UCB) Delayed: 34.23 +0.35 (1.03%)
Previous Close $33.88    52 Week High $ 
Open $34.01    52 Week Low $ 
Day High $34.41    P/E N/A 
Day Low $33.95    EPS $ 
Volume 1,020,288